HOTAIR and familial pancreatic carcinoma: HOTAIR promotes PACN-1 CSC self-renewal ability, growth, and migration by inhibiting the chemosensitivity of PACN-1 CSCs, supporting its potential as a new therapeutic target for pancreatic cancer [83].